Miniflam (Diclofenac Sodium)

Diclofenac Sodium, the active ingredient in Miniflam, is a nonsteroidal anti-inflammatory drug (NSAID) presented as a topical formulation for local application. It works by inhibiting cyclooxygenase enzymes, thereby decreasing prostaglandin synthesis, which helps to alleviate pain, swelling, and stiffness in affected tissues.

GNH USA supplies Miniflam as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies, and clinics worldwide through regulated distribution channels. The company adheres to stringent quality standards and supports customers with logistics, regulatory support, and reliable supply chain management.

Diclofenac Sodium is used topically to manage pain and inflammation in musculoskeletal and dermatologic conditions.

- Osteoarthritis (knee): reduces joint pain and improves functional mobility. - Acute muscle sprain: alleviates localized pain and swelling. - Actinic keratosis: promotes clearance of precancerous skin lesions.

Topical diclofenac may cause a range of skin‑related reactions, from mild irritation to rare but serious systemic events.

Common Side Effects: - Skin irritation: mild burning or stinging at the application site. - Itching or pruritus: localized itching without rash. - Redness: erythema surrounding the treated area. - Dry skin: occasional flaking or dryness. - Rash: mild maculopapular eruption.

Serious or Rare Side Effects: - Allergic reaction: angioedema, swelling of face or throat. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Systemic toxicity: hepatic or renal impairment with extensive use. - Ulceration: rare ulcer formation on treated skin. - Cardiovascular events: increased risk of thrombotic events in susceptible individuals.

When using Miniflam, certain precautions help minimize risks and ensure safe application.

- Assess skin integrity: avoid use on broken, infected, or inflamed skin. - Limit application area: do not exceed the recommended surface area per dose. - Avoid occlusion: do not cover the treated area with airtight dressings unless directed. - Caution in cardiovascular disease: use under medical supervision if patient has heart disease. - Concomitant systemic NSAIDs: limit combined use to reduce gastrointestinal and renal risk. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Diclofenac sodium can interact with other medicines, affecting safety or efficacy.

Major Interactions (Avoid): - Systemic NSAIDs: increased risk of gastrointestinal bleeding and ulceration. - Anticoagulants (e.g., warfarin): heightened bleeding tendency. - Lithium: potential rise in serum lithium levels leading to toxicity.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: possible reduction in renal function, especially in dehydrated patients. - Diuretics: may enhance renal adverse effects when combined with topical NSAIDs.